CCCC
C4 Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD5.13
+0.78 (+17.82%)
Rating:C
Company Profile
CEO
Andrew J. Hirsch
IPO Date
2020-10-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$4.35
Prev. Close
$4.35
Day Low
$4.33
Day High
$5.14
52W Low
$1.40
52W High
$5.14
Market Cap
$0.42B
Volume
3.23M